August 2, 2024: Blood Clots, DVT, Pulmonary Embolisms Possibly Linked to GLP-1 Drugs A data analysis published in the Endocrine Journal has medical professionals taking a new look at how semaglutide drugs might cause a specific type of blood clot
The results were striking: 65% of patients in the combination group achieved a greater than 50% reduction in their neuropathy symptom scores, a statistically superior outcome compared to only 10.5% in the Benfotiamine-only group and 27.7% in the Lipoic Acid-only group
The reduction in LFC was significantly correlated ( p 0.0006) with baseline LFC ( = 0.71), reductions in visceral adipose tissue (VAT) ( = 0.29), reductions in the transaminase liver enzyme ASAT ( = 033), and reductions in body weight ( p = 034) in the tirzepatide groups (79)
l que essa gordura transformada em combustvel para os msculos
Liu Y, Liu S, Tomar A, Yen FS, Unlu G, Ropek N, et al